Hepatology International

简称 HEPATOL INT ·UNITED STATES ·出版周期 Quarterly ·年均收录 91 篇

6.1

最新影响因子

4.70%

自引率

较易

投稿难度

较慢,6-12周

审稿周期

期刊简介

Hepatology International是一本专注于肝脏病学领域的国际期刊，ISSN号为1936-0533，由Springer Nature出版，出版地为美国，出版周期为季刊。该期刊是SCI收录期刊，2022年影响因子为6.4，属于中科院分区医学大类2区，目前采用混合开放获取（OA）模式。杂志主要发表肝脏疾病的基础与临床研究，涵盖肝炎、肝硬化、肝癌、脂肪肝等方向，尤其关注亚太地区的肝病问题，发文特点包括原创研究、综述和指南。杂志质量较高，审稿严格，但作为行业专刊，投稿竞争较激烈，接收率相对较低，需注意研究新颖性和临床价值。

影响因子趋势

近期发表

Dynamic changes in controlled attenuation parameter (CAP) improve prognostic prediction for CHB patients with significant fibrosis and cirrhosis 2026-09-19

Coronary atherosclerosis across stages of metabolic dysfunction–associated steatotic liver disease: a VCTE–CCTA study 2026-09-16

How to apply artificial intelligence (AI) to facilitate and enhance MASH trials 2026-09-16

Noninvasive surrogate endpoints in MASH trials: current perspectives and challenges 2026-09-13

Real-world outcomes of lenvatinib versus sorafenib as the second-line therapy after atezolizumab plus bevacizumab in patients with hepatocellular carcinoma: a large-scale multicenter study in Korea 2026-09-11

Antiviral therapies are associated with reduced mortality but under-utilized in patients with viral hepatocellular carcinoma: a multinational REAL-HCC study 2026-09-11

Alcohol and dementia: is hepatic steatosis an innocent bystander or an active contributor to cognitive decline? 2026-09-09

Matrix stiffness shapes early transcriptional trajectories during hepatic stellate cell activation 2026-09-02

Contemporary epidemiology and real-world management of hepatocellular carcinoma (HCC) in Australia: insights from a prospective Australian National Clinical Quality Registry 2026-08-28

Clonal hematopoiesis of indeterminate potential and metabolic dysfunction-associated steatotic liver disease: Korean biopsy cohort 2026-08-27